硅基仿生荣膺2024全球医疗技术创新奖，闪耀第二届全球医疗科技大会

Group 1 - The global medical technology sector is experiencing significant innovation and competition, highlighted by the second Global Medical Technology Conference held in Beijing, which attracted over 500 professionals from various sectors [1][3] - The conference focused on key topics such as "technology innovation + clinical traction + results transformation," aiming to promote cross-field integration and the transformation of technological achievements in medical technology [1] - Liu Hui, Director of the Beijing Pharmaceutical Health Technology Development Center, emphasized the importance of optimizing the innovation ecosystem and supporting medical technology companies in areas like approval, registration, and clinical validation [3] Group 2 - Silicon-based Bionic, established in 2015, specializes in blood glucose monitoring and is committed to global innovation and popularization of continuous monitoring products [5] - The company has nearly 700 employees and is led by a core team of scientists from prestigious universities, showcasing strong research and development capabilities [5] - The company aims to provide smarter, more accessible, and warmer health services, embodying the mission of "innovating medical technology to serve public health" [5] Group 3 - Winning the 2024 Global Medical Technology Innovation Award marks a significant milestone for Silicon-based Bionic and reflects China's achievements in independent medical technology innovation [7] - The company is transitioning from "Made in China" to "Chinese brand," positioning itself as a leader in the international diabetes management field through technology breakthroughs and global strategies [7] - Future plans include focusing on chronic disease management and health management needs, extending physiological monitoring technology, and establishing CXM as a global leading brand [7]